When developing and commercializing a pharmaceutical product, new study ideas need to be clearly evaluated for Strategic Fit to ensure they reflect the overall strategy for the product.
This includes considering the study feasibility, availability of budget and how the results will enhance the commercialization and further development of the product.
This kind of evaluation should apply to all study ideas from the start of the development cycle, even those entering the laboratory phase, and as the product moves through its life cycle, strategic fit should be modified to address data gaps identified through continuous assessment of the needs of the product.